Head and Neck Neoplasm: Clinical Trials

7 trials for Head and Neck Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Terminated 1, Unknown 1
Phase 21Completed 1

Follow Head and Neck Neoplasm: new trials by email Literature Review of Head and Neck Neoplasm trials Research Report on Head and Neck Neoplasm

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
GH21 Capsule - Advanced Solid Tumor, Non-Small Cell Lung Cancer
Phase 1UnknownSuzhou Genhouse Bio Co., Ltd.682022-02-202024-07-16
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy - Head and Neck Neoplasm
Phase 1CompletedMedical College of Wisconsin182021-01-262026-09-21
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
SZKJT(San-Zhong-Kui-Jian-Tang) - Head and Neck Neoplasm, Chemoradiotherapy
Phase 1CompletedChina Medical University Hospital212018-07-072022-10-26
HARE-40: HPV Anti-CD40 RNA vaccinE
BNT113 - Human Papilloma Virus Related Carcinoma, Head and Neck Neoplasm
Phase 1 / Phase 2CompletedUniversity of Southampton302017-04-112026-10-07
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
131I-Tenatumomab - Breast Neoplasm, Head and Neck Neoplasm
Phase 1Terminatedsigma-tau i.f.r. S.p.A.22015-11-012018-09-18
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
PF00562271 - Head and Neck Neoplasm, Prostatic Neoplasm
Phase 1CompletedVerastem, Inc.992005-12-012013-03-21
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
paclitaxel concurrent with radiation therapy - Head and Neck Neoplasm, Squamous Cell Carcinoma
Phase 1CompletedNational Cancer Institute (NCI)351995-07-012008-03-04

Narrower conditions

Head and Neck Neoplasms (7)  ·  Pancreatic Neoplasms (3)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Unknown Primary (1)  ·  Penile Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Respiratory Tract Neoplasms (1)  ·  Skin Neoplasms (1)

Broader conditions

Neoplasms by Site (7)  ·  Neoplasms (6)  ·  Digestive System Diseases (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pancreatic Diseases (3)  ·  Urogenital Diseases (3)  ·  Digestive System Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Neoplasms by Histologic Type (2)

Interventions

PF-00562271 (1)  ·  Radiotherapy (1)  ·  atezolizumab (1)

Sponsors

China Medical University Hospital (1)  ·  Medical College of Wisconsin (1)  ·  National Cancer Institute (NCI) (1)  ·  Suzhou Genhouse Bio Co., Ltd. (1)  ·  University of Southampton (1)  ·  Verastem, Inc. (1)  ·  sigma-tau i.f.r. S.p.A. (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Christian Ottensmeier, Prof (1)  ·  Haidan Wang, Doctorate (1)  ·  Ioannis Karydis, Dr (1)  ·  Ming-Yu Lien, Ph.D (1)  ·  Musaddiq Awan, MD (1)

Results publications

PMID 40123292

NIH funding

2014 (2), R21CA256144 (1)